Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OS ...

Observational data were used to “emulate a hypothetical trial”[2, 3] with three dosing intervals: subsequent denosumab injection 24-28 weeks after prior dose (“on time ... How to estimate the effect ...

Meanwhile, it booked another $2 billion from Xgeva, a higher-dose denosumab-based product used to treat tumours that have spread to the bone, as well as cancer-related hypercalcaemia. "This ...

Amgen’s Prolia and Xgeva were initially approved in 2010 to treat osteoporosis and skeletal weakening in patients with bone metastases from solid tumors, respectively. Both therapies leverage ...

Side effects of biologic drugs may include: respiratory infections headaches flu-like symptoms swelling, itching, or a rash at the injection ... of your treatment options. Use this article to ...

Scientists at the University of Toronto are developing a groundbreaking treatment that could replace the need for daily eye drops for glaucoma patients with a single injection under the eyelid.

Phenylephrine hydrochloride Injection is used for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia and is packaged in 10 mL vial ...

Medicare only covers PRP injections ... the treatment medically reasonable and necessary. With this in mind, the CMS states that there is currently insufficient evidence to support the use of ...

In many cases, cancer patients who undergo surgeries, radiation therapy, or chemotherapy, have to take immunotherapy drugs at home for long, even in many cases entire lifetime ...